Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityVTWV / Vanguard Russell 2000 Value ETF (92206C649)
Institutional Owners48
Institutional Shares442,201
Institutional Value$ 47,060,000 USD
Related VCIT / Vanguard Intermediate-Term Corporate Bond Index Fund
VGIT / Vanguard Intermediate-Term Government Bond Index Fund
VCLT / Vanguard Long-Term Corporate Bond Index Fund
VGLT / Vanguard Long-Term Government Bond Index Fund
VMBS / Vanguard Mortgage-Backed Securities Index Fund
VONE / Vanguard Russell 1000 ETF
VONG / Vanguard Russell 1000 Growth ETF
VONV / Vanguard Russell 1000 Value ETF
VTWO / Vanguard Russell 2000 ETF
VTWG / Vanguard Russell 2000 Growth ETF
VTHR / Vanguard Russell 3000 ETF
VCSH / Vanguard Short-Term Corporate Bond Index Fund
VGSH / Vanguard Short-Term Government Bond Index Fund

Institutional Stock Ownership and Shareholders()

VTWV / Vanguard Russell 2000 Value ETF Institutional Ownership

Vanguard Russell 2000 Value ETF (NASDAQ:VTWV) has 48 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 442,201 shares. Largest shareholders include Morgan Stanley, Relaxing Retirement Coach, Stordahl Capital Management, Inc., Franklin Resources Inc, UBS Group AG, Bank Of America Corp /de/, Commonwealth Equity Services, Llc., Commonwealth Equity Services, Inc, Eqis Capital Management, Inc., and Private Advisor Group, LLC.
Vanguard Russell 2000 Value ETF (NASDAQ:VTWV) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/vtwv"><img src="https://images.fintel.io/us-vtwv-so.png" alt="VTWV / Vanguard Russell 2000 Value ETF Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 17,616 17,406 -1.19 1,930 1,852 -4.04
2018-05-15 13F-HR Advisor Group, Inc. 3,456 3,491 1.01 379 371 -2.11
2018-05-18 13F-HR CIBC World Markets Inc. 0 9,639 0 1,026
2018-05-23 13F-HR Financial Gravity Wealth, Inc. 92 10
2018-05-15 13F-HR LPL Financial LLC 14,517 14,064 -3.12 1,591 1,496 -5.97
2018-05-11 13F-HR Relaxing Retirement Coach 47,976 39,322 -18.04 5,258 4,187 -20.37
2017-01-13 13F-HR MetLife Securities, Inc 66 67 1.52 6 7 16.67
2018-04-20 13F-HR Seacrest Wealth Management, Llc 100 100 0.00 11 11 0.00
2018-04-23 13F-HR Stordahl Capital Management, Inc. 34,779 35,749 2.79 3,811 3,804 -0.18
2018-05-09 13F-HR Private Advisor Group, LLC 0 15,419 0 1,641
2018-05-07 13F-HR FIDUCIARY TRUST CO 6,100 6,100 0.00 668 649 -2.84
2018-05-15 13F-HR HighTower Advisors, LLC 4,401 2,488 -43.47 483 266 -44.93
2018-06-28 13F-HR/A BROWN ADVISORY INC 5,349 0 -100.00 586 0 -100.00
2018-05-15 13F-HR UBS Group AG 24,045 25,105 4.41 2,634 2,671 1.40
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-05-04 13F-HR Financial Gravity Companies, Inc. 92 10
2018-05-11 13F-HR CITIGROUP INC 359 240 -33.15 39 25 -35.90
2018-05-14 13F-HR Bragg Financial Advisors, Inc 11,185 11,455 2.41 1,226 1,219 -0.57
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 427 445 4.22 47 47 0.00
2018-05-17 13F-HR Atlantic Trust Group, LLC 1,000 106
2018-05-02 13F-HR FTB Advisors, Inc. 120 0 -100.00 13 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 72,189 70,443 -2.42 7,910 7,495 -5.25
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 10,917 11,077 1.47 1,196 1,179 -1.42
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 109 0 12
2018-05-15 13F-HR PATHSTONE FAMILY OFFICE, LLC 1,175 1,177 0.17 129 125 -3.10
2018-04-20 13F-HR ARTHUR M. COHEN & ASSOCIATES, LLC 9,028 9,037 0.10 990 941 -4.95
2018-05-15 13F-HR Edge Advisors, Llc 931 931 0.00 102 99 -2.94
2018-04-12 13F-HR Integrated Investment Consultants, LLC 2,012 2,012 0.00 217 214 -1.38
2018-04-19 13F-HR Janney Montgomery Scott LLC 15,360 15,203 -1.02 1,683 1,618 -3.86
2018-05-14 13F-HR Proficio Capital Partners LLC 770 770 0.00 84 82 -2.38
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 17,930 17,359 -3.18 1,844 1,870 1.41
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 11,410 11,672 2.30 1,251 1,242 -0.72
2018-05-11 13F-HR Private Ocean, LLC 38 4
2018-05-01 13F-HR Landmark Financial Advisors, LLC 2,054 0 -100.00 225 0 -100.00
2018-07-12 13F-HR/A Guidant Wealth Advisors 1,421 1,357 -4.50 150 158 5.33
2018-04-25 13F-HR SONATA CAPITAL GROUP INC 2,200 2,200 0.00 241 234 -2.90
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 24,357 21,873 -10.20 2,669 2,327 -12.81
2018-05-02 13F-HR Financial Advisory Service, Inc. 11,618 1,236
2018-05-07 13F-HR BAILARD, INC. 4,238 3,909 -7.76 464 416 -10.34
2018-04-23 13F-HR Advisory Services Network, LLC 4,653 4,653 0.00 510 495 -2.94
2018-05-11 13F-HR First Allied Advisory Services, Inc. 326 0 -100.00 35 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 3,405 3,583 5.23 374 381 1.87
2018-05-14 13F-HR Virtu Financial LLC 2,315 5,425 134.34 253 575 127.27
2018-04-06 13F-HR Eqis Capital Management, Inc. 16,625 1,769
2018-05-15 13F-HR JANE STREET GROUP, LLC 0 15,034 0 1,600
2018-05-09 13F-HR Cetera Advisors LLC 0 3,197 0 340
2018-05-15 13F-HR BLAIR WILLIAM & CO/IL 50 5
2018-05-10 13F-HR FRANKLIN RESOURCES INC 25,605 25,605 0.00 2,798 2,716 -2.93
2018-05-14 13F-HR PAPP L ROY & ASSOCIATES 2,290 244
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 0 109 0 12
2018-05-11 13F-HR MML INVESTORS SERVICES, LLC 2,485 2,373 -4.51 272 252 -7.35
2018-05-14 13F-HR Gryphon Financial Partners Llc 197 21

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Should Vanguard Russell 2000 Value ETF (VTWV) Be on Your Investing Radar?

2018-05-22 zacks
If you're interested in broad exposure to the Small Cap Value segment of the US equity market, look no further than the Vanguard Russell 2000 Value ETF (VTWV - Free Report) , a passively managed exchange traded fund launched on 09/22/2010. (44-0)

CUSIP: 92206C649